I’m not disagreeing with you, but 008 readout for duration of therapeutic benefit was only 2-3 months ago. MRI data for 6month follow up, was also 2-3 months ago. I’m purely saying, if deals are written, one would think it’s sooner rather than later.
shortly we should hear back on the amendment outcomes to the dose for remainder of the phase 3 trial. I personally think this is critical. Others call it noise.
No one needs to be educated now. We all just want to see Deals! PAUL ffs, deals mate!!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-207
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |